Precision Optics (POCI)
Designs and manufactures medical-imaging systems and optical components for defence and aerospace.
Something off on this page? Send us feedback.
Produces medical-imaging systems and miniature optical components, then carries customer programs from development into manufacturing. Its operating areas combine systems manufacturing, engineering and product development, Ross Optical components and assemblies, and a micro-optics laboratory for medical and defence/aerospace applications.
Designs and manufactures miniature optical systems for medical imaging and defence/aerospace uses. Its systems manufacturing, engineering and product development, Ross Optical components and assemblies, and micro-optics laboratory connect customer programs from concept through production.
Medical products include endoscopes, endocouplers, CMOS-based digital-imaging endoscopes, custom imaging and illumination products, Microprecision lenses, and complete medical devices. Ross Optical supplies lenses, prisms, mirrors, windows, coatings, and mechano-optical assemblies to defence, medical, and industrial applications.
Operations are concentrated in Massachusetts, with additional facilities in Texas and Maine. The business depends on customer programs advancing from engineering work to later-volume manufacture and on serving regulated medical-device and defence/aerospace applications.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Mar 31, 2026Cash & short-term investments $10.7M · Total debt $4.3M · Total assets $33.7M · Shareholders' equity $20.1M
- Revenue
- $8.7M
- Operating income
- −$64.5K
- Net income
- −$108.3K
No dividends on record.
| Institutions | 33.41% | 3.66M shares | |
|---|---|---|---|
| 31 holders · as of Jun 30, 2026 | |||
| Insiders | 11.65% | 1.28M shares | |
| 8 holders · as of Aug 13, 2026 | |||
| Strategic holders | 15.26% | 1.67M shares | |
| 1 holder · as of May 14, 2026 | |||
| Other | 39.68% | 4.34M shares | |
| remainder | |||
10.94M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Needham Investment Management LLCInstitution | 15.26% | 1.67M | as of Jun 30, 2026 |
Needham Investment Management L.L.C.Strategic | 15.26% | 1.67M | filed May 14, 2026 |
Pessin Brian L.Insider | 5.03% | 550,673 | filed Mar 31, 2026 |
Myda Advisors LLCInstitution | 3.43% | 375,000 | as of Jun 30, 2026 |
Peter H. WoodwardInsiderdirector | 3.13% | 342,635 | filed May 20, 2025 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Mar 30, 2026 | Joseph Traut | officer: Chief Operating Officer | +41,666 | $3.60 |
| Mar 30, 2026 | Joseph Norman Forkey | director, officer: Chief Executive Officer | +1,388 | $3.60 |
| Mar 30, 2026 | Wayne M. Coll | officer: Chief Financial Officer | +20,833 | $3.60 |
- LightPath Technologies
Precision optical components and assemblies for medical and defense uses
- Teledyne Technologies
Digital imaging and aerospace/defense systems for high-reliability markets
- Stryker
Surgical endoscopy platforms and camera systems for clinical procedures
- CONMED
Single-use and capital endoscopic products for surgical procedures
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Precision Optics | $4.75 | +3.60% | $50.2M | — | — | 1.7 | +107.8% |
| LightPath Technologies | $10.02 | −1.33% | $637.3M | — | — | 8.9 | +73.5% |
| Teledyne Technologies | $621.81 | +1.48% | $28.40B | 29.6 | 24.4 | 4.5 | +9.8% |
| Stryker | $273.54 | −0.56% | $105.45B | 28.5 | 17.1 | 4.1 | +9.4% |
| CONMED | $45.73 | −0.95% | $1.38B | 24.9 | 10.2 | 1.0 | +0.3% |
| Median | 28.5 | 17.1 | 4.3 | +9.6% |